Our finding that MB can attenuate the increases in the serum levels of IL-6 in LPS-administered mice has indicated the therapeutic potential of MB for multiple diseases: Cumulative evidence has indicated that increased IL-6 is a key factor initiating cytokine storm, which plays crucial roles in such pathology as COVID-19-induced severe syndrome (22, 53). Here, IL6 is linked to COVID-19.